MedChem Express

MedChem Express logo

MedChemExpress has an experienced team of custom synthesis chemists, led by an impressive group of Ph.D.'s. With this team, we have the capability of supporting all kinds of chemistry projects of multiple step syntheses of complex labeled molecules, including metabolites and steroids. Following scientific and technological innovation, challenging traditional thinking, MedChemExpress has always been committed to develop quality products that exceed international standards on cost and reliability, to create the most advanced synthetic route. With high experiences in preparing a large numbers of different biologically active molecules, we provide rapid synthesis of new products. That is why we can consistently deliver your custom synthesis compounds faster than any other company.

Company Website

Product Listing

IT1t 50mg  | ≥98%

MedChem Express

IT1t is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM. IC50 & Target: IC50: 2.1 nM (CXCL12/CXCR4 interaction)[1] In Vitro: The CXCR4 is involved in chemotaxis and serves as a coreceptor for T-tropic HIV-1 viral entry and in cancer metastasis. IT1t is a small, drug-like, isothiourea derivative. IT1t shows very […]

More Information Supplier Page

IT1t 100mg  | ≥98%

MedChem Express

IT1t is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM. IC50 & Target: IC50: 2.1 nM (CXCL12/CXCR4 interaction)[1] In Vitro: The CXCR4 is involved in chemotaxis and serves as a coreceptor for T-tropic HIV-1 viral entry and in cancer metastasis. IT1t is a small, drug-like, isothiourea derivative. IT1t shows very […]

More Information Supplier Page

IT1t (dihydrochloride) 10mg  | ≥98%

MedChem Express

IT1t dihydrochloride is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM. IC50 & Target: IC50: 2.1 nM (CXCL12/CXCR4 interaction)[1] In Vitro: The CXCR4 is involved in chemotaxis and serves as a coreceptor for T-tropic HIV-1 viral entry and in cancer metastasis. IT1t is a small, drug-like, isothiourea derivative. IT1t shows […]

More Information Supplier Page

IT1t (dihydrochloride) 50mg  | ≥98%

MedChem Express

IT1t dihydrochloride is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM. IC50 & Target: IC50: 2.1 nM (CXCL12/CXCR4 interaction)[1] In Vitro: The CXCR4 is involved in chemotaxis and serves as a coreceptor for T-tropic HIV-1 viral entry and in cancer metastasis. IT1t is a small, drug-like, isothiourea derivative. IT1t shows […]

More Information Supplier Page

IT1t (dihydrochloride) 25mg  | ≥98%

MedChem Express

IT1t dihydrochloride is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM. IC50 & Target: IC50: 2.1 nM (CXCL12/CXCR4 interaction)[1] In Vitro: The CXCR4 is involved in chemotaxis and serves as a coreceptor for T-tropic HIV-1 viral entry and in cancer metastasis. IT1t is a small, drug-like, isothiourea derivative. IT1t shows […]

More Information Supplier Page

IT1t (dihydrochloride) 100mg  | ≥98%

MedChem Express

IT1t dihydrochloride is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM. IC50 & Target: IC50: 2.1 nM (CXCL12/CXCR4 interaction)[1] In Vitro: The CXCR4 is involved in chemotaxis and serves as a coreceptor for T-tropic HIV-1 viral entry and in cancer metastasis. IT1t is a small, drug-like, isothiourea derivative. IT1t shows […]

More Information Supplier Page

IT1t (dihydrochloride) 5mg  | ≥98%

MedChem Express

IT1t dihydrochloride is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM. IC50 & Target: IC50: 2.1 nM (CXCL12/CXCR4 interaction)[1] In Vitro: The CXCR4 is involved in chemotaxis and serves as a coreceptor for T-tropic HIV-1 viral entry and in cancer metastasis. IT1t is a small, drug-like, isothiourea derivative. IT1t shows […]

More Information Supplier Page

IT1t (dihydrochloride) 10mM/1mL  | ≥98%

MedChem Express

IT1t dihydrochloride is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM. IC50 & Target: IC50: 2.1 nM (CXCL12/CXCR4 interaction)[1] In Vitro: The CXCR4 is involved in chemotaxis and serves as a coreceptor for T-tropic HIV-1 viral entry and in cancer metastasis. IT1t is a small, drug-like, isothiourea derivative. IT1t shows […]

More Information Supplier Page

Itacitinib 200mg  | ≥98%

MedChem Express

Itacitinib is a potent and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold over JAK3 and TYK2; Itacitinib is used in the research of myelofibrosis. IC50 & Target: JAK[1] In Vitro: Itacitinib (INCB039110) is a potent and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold […]

More Information Supplier Page

Itacitinib 1mg  | ≥98%

MedChem Express

Itacitinib is a potent and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold over JAK3 and TYK2; Itacitinib is used in the research of myelofibrosis. IC50 & Target: JAK[1] In Vitro: Itacitinib (INCB039110) is a potent and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold […]

More Information Supplier Page

Itacitinib 5mg  | ≥98%

MedChem Express

Itacitinib is a potent and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold over JAK3 and TYK2; Itacitinib is used in the research of myelofibrosis. IC50 & Target: JAK[1] In Vitro: Itacitinib (INCB039110) is a potent and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold […]

More Information Supplier Page

Itacitinib 10mg  | ≥98%

MedChem Express

Itacitinib is a potent and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold over JAK3 and TYK2; Itacitinib is used in the research of myelofibrosis. IC50 & Target: JAK[1] In Vitro: Itacitinib (INCB039110) is a potent and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold […]

More Information Supplier Page

Itacitinib 50mg  | ≥98%

MedChem Express

Itacitinib is a potent and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold over JAK3 and TYK2; Itacitinib is used in the research of myelofibrosis. IC50 & Target: JAK[1] In Vitro: Itacitinib (INCB039110) is a potent and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold […]

More Information Supplier Page

Itacitinib 100mg  | ≥98%

MedChem Express

Itacitinib is a potent and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold over JAK3 and TYK2; Itacitinib is used in the research of myelofibrosis. IC50 & Target: JAK[1] In Vitro: Itacitinib (INCB039110) is a potent and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold […]

More Information Supplier Page

Itacitinib 10mM/1mL  | ≥98%

MedChem Express

Itacitinib is a potent and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold over JAK3 and TYK2; Itacitinib is used in the research of myelofibrosis. IC50 & Target: JAK[1] In Vitro: Itacitinib (INCB039110) is a potent and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold […]

More Information Supplier Page

Itacitinib 10 mM * 1 mL  | 99.87%

MedChem Express

Itacitinib is an orally bioavailable and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold over JAK3 and TYK2; Itacitinib is used in the research of myelofibrosis.

More Information Supplier Page

Itacitinib 1 mg  | 99.87%

MedChem Express

Itacitinib is an orally bioavailable and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold over JAK3 and TYK2; Itacitinib is used in the research of myelofibrosis.

More Information Supplier Page

Itacitinib 5 mg  | 99.87%

MedChem Express

Itacitinib is an orally bioavailable and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold over JAK3 and TYK2; Itacitinib is used in the research of myelofibrosis.

More Information Supplier Page

Itacitinib 10 mg  | 99.87%

MedChem Express

Itacitinib is an orally bioavailable and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold over JAK3 and TYK2; Itacitinib is used in the research of myelofibrosis.

More Information Supplier Page

Itacitinib 50 mg  | 99.87%

MedChem Express

Itacitinib is an orally bioavailable and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold over JAK3 and TYK2; Itacitinib is used in the research of myelofibrosis.

More Information Supplier Page

Itacitinib 100 mg  | 99.87%

MedChem Express

Itacitinib is an orally bioavailable and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold over JAK3 and TYK2; Itacitinib is used in the research of myelofibrosis.

More Information Supplier Page

Itacitinib 200 mg  | 99.87%

MedChem Express

Itacitinib is an orally bioavailable and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold over JAK3 and TYK2; Itacitinib is used in the research of myelofibrosis.

More Information Supplier Page

Itacitinib adipate 10mM/1mL  | ≥98%

MedChem Express

Itacitinib adipate is a selective JAK1 inhibitor which has been tested for efficacy and safety in a phase II trial in myelofibrosis. IC50 & Target: JAK1[1]

More Information Supplier Page

Itacitinib adipate 50mg  | ≥98%

MedChem Express

Itacitinib adipate is a selective JAK1 inhibitor which has been tested for efficacy and safety in a phase II trial in myelofibrosis. IC50 & Target: JAK1[1]

More Information Supplier Page

Itacitinib adipate 1mg  | ≥98%

MedChem Express

Itacitinib adipate is a selective JAK1 inhibitor which has been tested for efficacy and safety in a phase II trial in myelofibrosis. IC50 & Target: JAK1[1]

More Information Supplier Page

Itacitinib adipate 5mg  | ≥98%

MedChem Express

Itacitinib adipate is a selective JAK1 inhibitor which has been tested for efficacy and safety in a phase II trial in myelofibrosis. IC50 & Target: JAK1[1]

More Information Supplier Page

Itacitinib adipate 100mg  | ≥98%

MedChem Express

Itacitinib adipate is a selective JAK1 inhibitor which has been tested for efficacy and safety in a phase II trial in myelofibrosis. IC50 & Target: JAK1[1]

More Information Supplier Page

Itacitinib adipate 10mg  | ≥98%

MedChem Express

Itacitinib adipate is a selective JAK1 inhibitor which has been tested for efficacy and safety in a phase II trial in myelofibrosis. IC50 & Target: JAK1[1]

More Information Supplier Page

Itacitinib adipate 10 mM * 1 mL  | 99.37%

MedChem Express

Itacitinib adipate is an orally bioavailable and selective JAK1 inhibitor which has been tested for efficacy and safety in a phase II trial in myelofibrosis.

More Information Supplier Page

Itacitinib adipate 1 mg  | 99.37%

MedChem Express

Itacitinib adipate is an orally bioavailable and selective JAK1 inhibitor which has been tested for efficacy and safety in a phase II trial in myelofibrosis.

More Information Supplier Page

Itacitinib adipate 5 mg  | 99.37%

MedChem Express

Itacitinib adipate is an orally bioavailable and selective JAK1 inhibitor which has been tested for efficacy and safety in a phase II trial in myelofibrosis.

More Information Supplier Page

Itacitinib adipate 10 mg  | 99.37%

MedChem Express

Itacitinib adipate is an orally bioavailable and selective JAK1 inhibitor which has been tested for efficacy and safety in a phase II trial in myelofibrosis.

More Information Supplier Page

Itacitinib adipate 50 mg  | 99.37%

MedChem Express

Itacitinib adipate is an orally bioavailable and selective JAK1 inhibitor which has been tested for efficacy and safety in a phase II trial in myelofibrosis.

More Information Supplier Page

Itacitinib adipate 100 mg  | 99.37%

MedChem Express

Itacitinib adipate is an orally bioavailable and selective JAK1 inhibitor which has been tested for efficacy and safety in a phase II trial in myelofibrosis.

More Information Supplier Page

Itanapraced 10 mM * 1 mL  | >98.00%

MedChem Express

Itanapraced (CHF5074) is a novel γ-secretase modulator, reduces Aβ42 and Aβ40 secretion, with an IC50 of 3.6 and 18.4 μM, respectively.

More Information Supplier Page

Itanapraced 5 mg  | >98.00%

MedChem Express

Itanapraced (CHF5074) is a novel γ-secretase modulator, reduces Aβ42 and Aβ40 secretion, with an IC50 of 3.6 and 18.4 μM, respectively.

More Information Supplier Page

Itanapraced 10 mg  | >98.00%

MedChem Express

Itanapraced (CHF5074) is a novel γ-secretase modulator, reduces Aβ42 and Aβ40 secretion, with an IC50 of 3.6 and 18.4 μM, respectively.

More Information Supplier Page

Itanapraced 50 mg  | >98.00%

MedChem Express

Itanapraced (CHF5074) is a novel γ-secretase modulator, reduces Aβ42 and Aβ40 secretion, with an IC50 of 3.6 and 18.4 μM, respectively.

More Information Supplier Page

Itanapraced 100 mg  | >98.00%

MedChem Express

Itanapraced (CHF5074) is a novel γ-secretase modulator, reduces Aβ42 and Aβ40 secretion, with an IC50 of 3.6 and 18.4 μM, respectively.

More Information Supplier Page

Itch-Targeting Compound 1 20mg  | ≥98%

MedChem Express

Itch-Targeting Compound 1 is an anti-itching agent. In Vitro: Anti-itching Compound 1 (Example 6-4) is effective in preventing itches and is useful for the prevention of or treatments for: reactions on insect’s bites, reactions on environmental allergens, skin infections, external vermination, or itches occurring in renal dialysis patients[1].

More Information Supplier Page

Itch-Targeting Compound 1 1mg  | ≥98%

MedChem Express

Itch-Targeting Compound 1 is an anti-itching agent. In Vitro: Anti-itching Compound 1 (Example 6-4) is effective in preventing itches and is useful for the prevention of or treatments for: reactions on insect’s bites, reactions on environmental allergens, skin infections, external vermination, or itches occurring in renal dialysis patients[1].

More Information Supplier Page

Itch-Targeting Compound 1 5mg  | ≥98%

MedChem Express

Itch-Targeting Compound 1 is an anti-itching agent. In Vitro: Anti-itching Compound 1 (Example 6-4) is effective in preventing itches and is useful for the prevention of or treatments for: reactions on insect’s bites, reactions on environmental allergens, skin infections, external vermination, or itches occurring in renal dialysis patients[1].

More Information Supplier Page

Itch-Targeting Compound 1 10mg  | ≥98%

MedChem Express

Itch-Targeting Compound 1 is an anti-itching agent. In Vitro: Anti-itching Compound 1 (Example 6-4) is effective in preventing itches and is useful for the prevention of or treatments for: reactions on insect’s bites, reactions on environmental allergens, skin infections, external vermination, or itches occurring in renal dialysis patients[1].

More Information Supplier Page